We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

79 hedge funds and large institutions have $17.6M invested in Acorda Therapeutics in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 27 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 106 → 79 (-27)

48% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 27

56% less capital invested

Capital invested by funds: $39.9M → $17.6M (-$22.3M)

60% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 45

96% less call options, than puts

Call options by funds: $101K | Put options by funds: $2.41M

Holders
79
Holders Change
-27
Holders Change %
-25.47%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
14
Reduced
27
Closed
45
Calls
$101K
Puts
$2.41M
Net Calls
-$2.31M
Net Calls Change
+$1.38M

Top Buyers

1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$515K
2
Millennium Management
Millennium Management
New York
+$400K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$249K
4
Jane Street
Jane Street
New York
+$229K
5
PP
Paloma Partners
Connecticut
+$210K

Top Sellers

1
BlackRock
BlackRock
New York
-$5.44M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.02M
3
PHS
PFM Health Sciences
California
-$1.42M
4
State Street
State Street
Massachusetts
-$1.28M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$777K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.94M -$373K -3,527 -10%
Renaissance Technologies
2
Renaissance Technologies
New York
$2.83M +$24.7K +234 +0.7%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$1.4M -$777K -7,352 -32%
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$1.38M +$249K +2,355 +18%
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$1.37M -$27.9K -264 -2%
BlackRock
6
BlackRock
New York
$840K -$5.44M -51,472 -84%
AQR Capital Management
7
AQR Capital Management
Connecticut
$706K +$68.9K +652 +9%
Federated Hermes
8
Federated Hermes
Pennsylvania
$486K +$181K +1,710 +45%
Millennium Management
9
Millennium Management
New York
$478K +$400K +3,785 +231%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$464K -$4.02M -37,999 -88%
Invesco
11
Invesco
Georgia
$435K -$346K -3,269 -40%
Arrowstreet Capital
12
Arrowstreet Capital
Massachusetts
$429K +$515K +4,868 New
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$416K -$82.7K -782 -14%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$355K +$2.75K +26 +0.6%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$268K -$248K -2,348 -44%
BCM
16
Bridgeway Capital Management
Texas
$254K +$137K +1,292 +82%
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$196K -$2.54K -24 -1%
Jane Street
18
Jane Street
New York
$191K +$229K +2,167 New
PP
19
Paloma Partners
Connecticut
$175K +$210K +1,990 New
Charles Schwab
20
Charles Schwab
California
$142K -$104K -982 -38%
Two Sigma Investments
21
Two Sigma Investments
New York
$139K -$281K -2,660 -63%
Parallax Volatility Advisers
22
Parallax Volatility Advisers
California
$138K +$5.92K +56 +4%
Goldman Sachs
23
Goldman Sachs
New York
$106K -$196K -1,850 -61%
Jacobs Levy Equity Management
24
Jacobs Levy Equity Management
New Jersey
$103K – – –
Northern Trust
25
Northern Trust
Illinois
$97K -$380K -3,595 -77%
1
2 3 4 5

ACOR Hedge Fund Activity: Q2 2020 in Review

79 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2020, worth a combined $17.6M — down 56% from $39.9M a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of ACOR and 18 opened new positions — a net loss of 27 holders — while 27 trimmed existing stakes and 14 added.

The largest buyer was Arrowstreet Capital, opening a new position worth an estimated $515K. The largest seller was BlackRock, cutting an estimated $5.44M.

  • 79 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2020, down from 106 in Q1 2020.
  • Funds reported $17.6M of Acorda Therapeutics stock for Q2 2020, down 56% quarter-over-quarter.
  • 18 funds opened new Acorda Therapeutics positions in Q2 2020 and 45 closed out, a net change of -27 holders.
  • The largest Acorda Therapeutics buyer in Q2 2020 was Arrowstreet Capital, an estimated $515K added.
  • The largest Acorda Therapeutics seller in Q2 2020 was BlackRock, an estimated $5.44M sold.

Based on aggregated 13F filings for Q2 2020.